Latest Insider Transactions at Myovant Sciences Ltd. (MYOV)
This section provides a real-time view of insider transactions for Myovant Sciences Ltd. (MYOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Myovant Sciences Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Myovant Sciences Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,478
+0.1%
|
$929,560
$20.86 P/Share
|
|
Aug 19
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,792
+0.1%
|
$982,632
$21.51 P/Share
|
|
Aug 18
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,116
+0.04%
|
$359,436
$21.45 P/Share
|
|
Aug 17
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
23,549
+0.05%
|
$470,980
$20.89 P/Share
|
|
Aug 16
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
48,167
+0.05%
|
$1,011,507
$21.62 P/Share
|
|
Jul 09
2021
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
6,954
-3.59%
|
$146,034
$21.52 P/Share
|
|
Jul 07
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
3,232
-1.5%
|
$67,872
$21.75 P/Share
|
|
Jul 07
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,777
-1.58%
|
$58,317
$21.75 P/Share
|
|
May 28
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.86%
|
$73,992
$24.0 P/Share
|
|
May 28
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+0.72%
|
$9,100
$7.78 P/Share
|
|
May 26
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,700
-6.66%
|
$304,800
$24.23 P/Share
|
|
May 26
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,700
+6.25%
|
$88,900
$7.78 P/Share
|
|
Apr 15
2021
|
Lauren Merendino Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,299
+50.0%
|
-
|
|
Apr 15
2021
|
David C Marek Principal Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134,789
+27.36%
|
-
|
|
Apr 15
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
63,138
+22.66%
|
-
|
|
Apr 15
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,446
+22.43%
|
-
|
|
Apr 15
2021
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
58,461
+23.21%
|
-
|
|
Apr 06
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
11,080
-6.78%
|
$199,440
$18.63 P/Share
|
|
Apr 06
2021
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
10,862
-7.45%
|
$195,516
$18.62 P/Share
|
|
Apr 06
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,114
-6.03%
|
$146,052
$18.63 P/Share
|
|
Mar 19
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-4.95%
|
$168,000
$24.17 P/Share
|
|
Mar 19
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.71%
|
$49,000
$7.78 P/Share
|
|
Mar 15
2021
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
30,000
-17.06%
|
$750,000
$25.07 P/Share
|
|
Mar 15
2021
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.57%
|
$210,000
$7.78 P/Share
|
|
Mar 01
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,513
-1.11%
|
$33,286
$22.55 P/Share
|
|
Feb 16
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
750
-0.46%
|
$15,750
$21.4 P/Share
|
|
Feb 16
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+0.45%
|
$3,750
$5.11 P/Share
|
|
Jan 28
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
300
-0.18%
|
$7,200
$24.0 P/Share
|
|
Jan 28
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+0.18%
|
$1,500
$5.11 P/Share
|
|
Jan 15
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
750
-0.46%
|
$15,750
$21.5 P/Share
|
|
Jan 15
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+0.45%
|
$3,750
$5.11 P/Share
|
|
Jan 15
2021
|
David C Marek Principal Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
223,076
+50.0%
|
-
|
|
Dec 28
2020
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
11,800
-6.73%
|
$354,000
$30.0 P/Share
|
|
Dec 28
2020
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
11,800
+6.31%
|
$59,000
$5.11 P/Share
|
|
Dec 18
2020
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
10,000
-3.21%
|
$250,000
$25.81 P/Share
|
|
Dec 18
2020
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.03%
|
$70,000
$7.78 P/Share
|
|
Dec 18
2020
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-1.45%
|
$52,000
$26.0 P/Share
|
|
Dec 18
2020
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.43%
|
$14,000
$7.78 P/Share
|
|
Dec 15
2020
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
670
-0.41%
|
$16,080
$24.45 P/Share
|
|
Dec 15
2020
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
380
-0.23%
|
$8,740
$23.63 P/Share
|
|
Dec 15
2020
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
1,050
+0.63%
|
$5,250
$5.11 P/Share
|
|
Dec 15
2020
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-2.48%
|
$161,000
$23.92 P/Share
|
|
Dec 15
2020
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.67%
|
$49,000
$7.78 P/Share
|
|
Dec 10
2020
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.85%
|
$260,000
$26.04 P/Share
|
|
Dec 10
2020
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.41%
|
$70,000
$7.78 P/Share
|
|
Dec 10
2020
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
19,400
-11.74%
|
$485,000
$25.2 P/Share
|
|
Dec 10
2020
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
19,400
+10.51%
|
$135,800
$7.78 P/Share
|
|
Dec 09
2020
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
600
-0.41%
|
$15,000
$25.08 P/Share
|
|
Dec 09
2020
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+0.41%
|
$4,200
$7.78 P/Share
|
|
Nov 30
2020
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
1,500
-0.91%
|
$36,000
$24.0 P/Share
|